GTC Biotherapeutics (fka GTCB)

[DewDiligence]

Notes on Artisan Pharma’s program in DIC/sepsis:

#msg-22260580 How big a threat is ART-123?
#msg-22257491 Phase-2b trial begins in US
#msg-21829339 clinicaltrials.gov listing of above trial
#msg-22326569 Paper on ART-123 study in Japan
#msg-22288440 Musings on the Japanese study (Dew)
#msg-22328879 Musings on the Japanese study (shears)